Stage III Hypopharyngeal Carcinoma AJCC v8

specific

Stage II includes: T2, N0, M0. T2: Tumor invading more than one subsite of hypopharynx or an adjacent site, or measuring more than 2 cm but not more than 4 cm in greatest dimension without fixation of hemilarynx. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)

71

Centers

132

Active Trials

Cancer Funding

Top Centers for Stage III Hypopharyngeal Carcinoma AJCC v8(71)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
72.9
2
NCI Comprehensive
High-Volume Research Center
72.3
370.0
4
NCI Comprehensive
High-Volume Research Center
70.0
5
NCI Comprehensive
High-Volume Research Center
70.0
6
NCI Comprehensive
High-Volume Research Center
70.0
7
NCI Comprehensive
High-Volume Research Center
70.0
8
High-Volume Research Center
70.0
9
NCI Comprehensive
Active Research Program
64.3
10
NCI Comprehensive
Active Research Program
64.3
11
NCI Comprehensive
Active Research Program
64.3
12
NCI Comprehensive
Active Research Program
64.3
13
NCI Clinical
Active Research Program
64.3
14
NCI Comprehensive
Active Research Program
64.3
15
Active Research Program
64.3
16
Active Research Program
64.3
17
NCI Comprehensive
Active Research Program
64.3
18
Active Research Program
64.3
19
Active Research Program
64.3
20
Active Research Program
64.3
21
NCI Comprehensive
Active Research Program
55.1
22
NCI Comprehensive
Active Research Program
55.1
23
NCI Comprehensive
Active Research Program
55.1
24
NCI Comprehensive
Active Research Program
55.1
25
NCI Comprehensive
Active Research Program
55.1
26
NCI Comprehensive
Active Research Program
55.1
27
NCI Comprehensive
Active Research Program
55.1
28
Active Research Program
55.1
29
Active Research Program
55.1
30
NCI Clinical
Active Research Program
55.1
31
NCI Comprehensive
Active Research Program
55.1
32
NCI Comprehensive
Active Research Program
55.1
33
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
55.1
34
NCI Clinical
Active Research Program
55.1
35
Active Research Program
55.1
36
Active Research Program
55.1
37
Active Research Program
55.1
38
NCI Comprehensive
Active Research Program
41.2
39
NCI Comprehensive
Active Research Program
41.2
40
NCI Comprehensive
Active Research Program
41.2
41
NCI Comprehensive
Active Research Program
41.2
42
NCI Comprehensive
Active Research Program
41.2
43
NCI Comprehensive
Active Research Program
41.2
44
NCI Comprehensive
Active Research Program
41.2
45
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
41.2
46
NCI Comprehensive
Active Research Program
41.2
47
NCI Comprehensive
Active Research Program
41.2
48
NCI Comprehensive
Active Research Program
41.2
49
NCI Comprehensive
Active Research Program
41.2
50
NCI Comprehensive
Active Research Program
41.2
51
NCI Comprehensive
Active Research Program
41.2
52
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
41.2
53
NCI Comprehensive
Active Research Program
41.2
54
NCI Comprehensive
Active Research Program
41.2
55
NCI Comprehensive
Active Research Program
41.2
56
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
41.2
5741.2
58
Active Research Program
41.2
59
Active Research Program
41.2
60
NCI Basic_laboratory
Active Research Program
41.2
61
Active Research Program
41.2
62
Active Research Program
41.2
63
Active Research Program
41.2
64
Active Research Program
41.2
65
NCI Comprehensive
30.4
66
NCI Comprehensive
30.4
67
NCI Comprehensive
30.4
68
NCI Comprehensive
30.4
6930.4
7030.4
7130.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →